Logo image of A7A.DE

HELIAD AG (A7A.DE) Stock Fundamental Analysis

FRA:A7A - Deutsche Boerse Ag - DE0001218063 - Common Stock - Currency: EUR

14.6  +0.2 (+1.39%)

Fundamental Rating

3

Taking everything into account, A7A scores 3 out of 10 in our fundamental rating. A7A was compared to 107 industry peers in the Capital Markets industry. A7A has a medium profitability rating, but doesn't score so well on its financial health evaluation. A7A is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year A7A was profitable.
In multiple years A7A reported negative net income over the last 5 years.
A7A had negative operating cash flow in 4 of the past 5 years.
A7A.DE Yearly Net Income VS EBIT VS OCF VS FCFA7A.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

A7A has a better Return On Assets (2.82%) than 64.91% of its industry peers.
A7A has a Return On Equity (3.59%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 1.67%, A7A is in line with its industry, outperforming 57.89% of the companies in the same industry.
Industry RankSector Rank
ROA 2.82%
ROE 3.59%
ROIC 1.67%
ROA(3y)-3.65%
ROA(5y)-2.19%
ROE(3y)-4.7%
ROE(5y)-2.82%
ROIC(3y)N/A
ROIC(5y)N/A
A7A.DE Yearly ROA, ROE, ROICA7A.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

Looking at the Profit Margin, with a value of 519.85%, A7A belongs to the top of the industry, outperforming 98.25% of the companies in the same industry.
A7A's Profit Margin has declined in the last couple of years.
The Operating Margin of A7A (431.95%) is better than 100.00% of its industry peers.
A7A's Operating Margin has improved in the last couple of years.
A7A has a better Gross Margin (93.38%) than 89.47% of its industry peers.
A7A's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 431.95%
PM (TTM) 519.85%
GM 93.38%
OM growth 3Y132.69%
OM growth 5Y55.14%
PM growth 3YN/A
PM growth 5Y-11.53%
GM growth 3Y-0.25%
GM growth 5YN/A
A7A.DE Yearly Profit, Operating, Gross MarginsA7A.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, A7A has about the same amount of shares outstanding.
The number of shares outstanding for A7A has been increased compared to 5 years ago.
A7A has a worse debt/assets ratio than last year.
A7A.DE Yearly Shares OutstandingA7A.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
A7A.DE Yearly Total Debt VS Total AssetsA7A.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 4.46 indicates that A7A is not in any danger for bankruptcy at the moment.
The Altman-Z score of A7A (4.46) is better than 84.21% of its industry peers.
A7A has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
A7A has a Debt to Equity ratio of 0.24. This is in the better half of the industry: A7A outperforms 71.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 4.46
ROIC/WACCN/A
WACCN/A
A7A.DE Yearly LT Debt VS Equity VS FCFA7A.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.3 Liquidity

A7A has a Current Ratio of 0.57. This is a bad value and indicates that A7A is not financially healthy enough and could expect problems in meeting its short term obligations.
A7A's Current ratio of 0.57 is in line compared to the rest of the industry. A7A outperforms 52.63% of its industry peers.
A Quick Ratio of 0.57 indicates that A7A may have some problems paying its short term obligations.
The Quick ratio of A7A (0.57) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.57
A7A.DE Yearly Current Assets VS Current LiabilitesA7A.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1

3. Growth

3.1 Past

A7A shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.16%, which is quite impressive.
The earnings per share for A7A have been decreasing by -46.21% on average. This is quite bad
Looking at the last year, A7A shows a very negative growth in Revenue. The Revenue has decreased by -40.16% in the last year.
The Revenue for A7A have been decreasing by -33.67% on average. This is quite bad
EPS 1Y (TTM)114.16%
EPS 3YN/A
EPS 5Y-46.21%
EPS Q2Q%144.44%
Revenue 1Y (TTM)-40.16%
Revenue growth 3Y-52.27%
Revenue growth 5Y-33.67%
Sales Q2Q%611.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
A7A.DE Yearly Revenue VS EstimatesA7A.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
A7A.DE Yearly EPS VS EstimatesA7A.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2023 2024 2025 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 44.24, A7A can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of A7A is on the same level as its industry peers.
When comparing the Price/Earnings ratio of A7A to the average of the S&P500 Index (26.25), we can say A7A is valued expensively.
A Price/Forward Earnings ratio of 72.28 indicates a quite expensive valuation of A7A.
A7A's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.15. A7A is valued rather expensively when compared to this.
Industry RankSector Rank
PE 44.24
Fwd PE 72.28
A7A.DE Price Earnings VS Forward Price EarningsA7A.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
A7A.DE Per share dataA7A.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for A7A!.
Industry RankSector Rank
Dividend Yield N/A

HELIAD AG

FRA:A7A (5/30/2025, 7:00:00 PM)

14.6

+0.2 (+1.39%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-30 2025-04-30
Earnings (Next)09-29 2025-09-29
Inst Owners0.89%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap122.79M
Analysts80
Price Target15.81 (8.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 44.24
Fwd PE 72.28
P/S 232.11
P/FCF N/A
P/OCF N/A
P/B 1.6
P/tB 1.6
EV/EBITDA N/A
EPS(TTM)0.33
EY2.26%
EPS(NY)0.2
Fwd EY1.38%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.06
BVpS9.11
TBVpS9.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.82%
ROE 3.59%
ROCE 2.93%
ROIC 1.67%
ROICexc 1.79%
ROICexgc 1.79%
OM 431.95%
PM (TTM) 519.85%
GM 93.38%
FCFM N/A
ROA(3y)-3.65%
ROA(5y)-2.19%
ROE(3y)-4.7%
ROE(5y)-2.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-8.62%
ROICexcg growth 5Y12.14%
ROICexc growth 3Y-8.62%
ROICexc growth 5Y12.14%
OM growth 3Y132.69%
OM growth 5Y55.14%
PM growth 3YN/A
PM growth 5Y-11.53%
GM growth 3Y-0.25%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.57
Altman-Z 4.46
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.16%
EPS 3YN/A
EPS 5Y-46.21%
EPS Q2Q%144.44%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.16%
Revenue growth 3Y-52.27%
Revenue growth 5Y-33.67%
Sales Q2Q%611.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y454.81%
EBIT growth 3Y11.06%
EBIT growth 5Y2.9%
EBIT Next Year-100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A